Controlling the type 1 error rate in non-inferiority trials

Steven Snapinn1, Qi Jiang

  • 1Amgen Inc., One Amgen Center Drive, 24-2-C, Thousand Oaks, CA 91320, USA. ssnapinn@amgen.com

Statistics in Medicine
|October 5, 2007
PubMed

Insights

This study introduces a unified approach for non-inferiority trials, enhancing experimental therapy efficacy evaluation. The proposed method offers better power and error control compared to traditional fixed-margin approaches.

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Pharmaceutical Research

Background:

  • Non-inferiority trials are crucial for evaluating experimental therapies against established controls.
  • Existing methods include fixed-margin and synthesis approaches, each with limitations.

Purpose of the Study:

  • To introduce a unified approach for non-inferiority trials that encompasses both fixed-margin and synthesis methods.
  • To demonstrate how this unified approach controls type 1 error rates, even with violated assumptions.
  • To compare the efficiency and power of the unified approach against the fixed-margin method.

Main Methods:

  • Development of a unified statistical framework for non-inferiority trial design.
  • Parameter selection strategies to control unconditional type 1 error rates.
  • Analysis of assay sensitivity and constancy assumption departures.

Main Results:

  • The unified approach integrates fixed-margin and synthesis methods as special cases.
  • The fixed-margin approach can be highly inefficient.
  • The synthesis method, when appropriately chosen, offers equivalent type 1 error control with higher statistical power.

Conclusions:

  • The unified approach provides a flexible and powerful framework for non-inferiority trial design.
  • Synthesis methods are generally superior to fixed-margin approaches for maximizing power while maintaining error control.
  • This research offers improved statistical strategies for experimental therapy evaluation.

Related Concept Videos

Errors In Hypothesis Tests01:14

Errors In Hypothesis Tests

When performing a hypothesis test, there are four possible outcomes depending on the actual truth (or falseness) of the null hypothesis and the decision to reject or not.
Accuracy and Errors in Hypothesis Testing01:13

Accuracy and Errors in Hypothesis Testing

Hypothesis testing is a fundamental statistical tool that begins with the assumption that the null hypothesis H0 is true. During this process, two types of errors can occur: Type I and Type II. A Type I error refers to the incorrect rejection of a true null hypothesis, while a Type II error involves the failure to reject a false null hypothesis.
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5% chance...
Bonferroni Test01:10

Bonferroni Test

The Bonferroni test is a statistical test named after Carlo Emilio Bonferroni, an Italian mathematician best known for Bonferroni inequalities. This statistical test is a type of multiple comparison test to determine which means are different than the rest. Bonferroni test can minimize the Type 1 error by reducing the significance level alpha, which otherwise increases with sample pairs.
The means of different samples are first paired in all possible combinations.
The null hypothesis of the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...